Your trusted destination for CME, CPD & Medical Education across the Middle East.
The International Summit on Organoid Research and Regenerative Health (ISORRH-26) is a hybrid conference taking place from October 10-11, 2026. Organized by the IAAR, this summit offers a platform for researchers and scholars to share advancements in organoid technology and regenerative medicine.
Join leading researchers, scholars, scientists, and industry professionals at the International Summit on Organoid Research and Regenerative Health (ISORRH-26), a premier hybrid event scheduled for October 10-11, 2026. This summit, organized by the International Alliance for Academic Research (IAAR), provides an exceptional opportunity to explore the latest innovations and applications in organoid research. Attendees will engage in discussions on stem cell science, disease modeling, clinical applications, and tissue engineering, fostering global collaboration and knowledge exchange in this cutting-edge field.
Exploring new technologies for scaling up organoid production and maintaining complex 3D structures.
Utilizing organoids for large-scale drug discovery and toxicity testing.
Advanced microscopy and computational methods for visualizing and quantifying organoid development and function.
Protocols and techniques for directing iPSCs and ESCs into specific organoid lineages.
Harnessing tissue-specific stem cells for generating patient-derived organoids.
Understanding the intrinsic cellular mechanisms that drive the formation of complex organ structures in vitro.
Using organoids to study host-pathogen interactions for viruses and bacteria.
Creating patient-specific organoid models to investigate the mechanisms of genetic diseases and oncogenesis.
Developing organoid systems to explore the pathology of neurodegenerative and other chronic conditions.
Tailoring treatments based on drug responses in patient-derived organoids.
Exploring the potential of organoids and organoid-derived cells for tissue repair and transplantation.
Discussing the challenges in translating organoid-based therapies from the lab to the clinic.
Developing synthetic and natural matrices to support organoid growth and maturation.
Strategies for incorporating blood vessel networks to improve the viability and function of large organoids.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow